Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TAMSIN PROLONGED RELEASE TABLET 0.4MG

Approval Number

SIN15476P

Drug Name

TAMSIN PROLONGED RELEASE TABLET 0.4MG

Product Name

TAMSIN PROLONGED RELEASE TABLET 0.4MG

Approval Date

May 3, 2018

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route of Administration

ORAL

Medical Information

ATC Code

G04CA02

ATC Item Name

tamsulosin

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

Synthon Hispania S.L.

GE Pharmaceuticals, Ltd. (Primary & Secondary Packager)

Rottendorf Pharma GmbH

Active Ingredients

Ingredient Name

Tamsulosin 0.367mg eqv Tamsulosin Hydrochloride

Strength

0.4mg

Drug MonographTamsulosin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy